Through the use of JAM-C-deficient mice and/or blocking antibodies, the role of JAM-C has been investigated in numerous disease models such as models of arthritis (12), peritonitis (13), acute pancreatitis (14), ischemia-reperfusion injury (11), and pulmonary inflammation (15, 16). This evidence concerns the gene JAM3 and peritonitis.